Neupro can treat Parkinson's disease and Restless Legs Syndrome

Share this article:
Neupro can treat Parkinson's disease and Restless Legs Syndrome
Neupro can treat Parkinson's disease and Restless Legs Syndrome

UCB has announced the launch of Neupro in the United States for the treatment of Parkinson's disease and restless legs syndrome. The once-daily patch provides continuous delivery of the dopamine agonist rotigotine. The Food & Drug Administration approved the medication in April. Parkinson's affects about one million Americans, while up to 23 million Americans may be afflicted by Restless Leg Syndrome.

Share this article:
close

Next Article in Products

More in Products

Higher rates of mortality seen with benzodiazepine sedatives, study says

Continuous infusion benzodiazepines, a group of sedatives often used to treat intensive-care unit patients on ventilators, are linked to an increased likelihood of death compared to those who received propofol, a new study says.

Drive Medical introduces long-term care beds

Drive Medical introduces long-term care beds

Drive Medical is offering four new long-term care beds, including two models designed with the bariatric resident in mind.

New footwear sanitizing system released

New footwear sanitizing system released

Best Sanitizers Inc. has announced the HACCP SmartStep™ Footwear Sanitizing System. The system reduces cross-contamination from footwear for employees working in labs, clean rooms or in pharmaceutical plants.